Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection

S G Rønn, A Börjesson, C Bruun, P E Heding, H Frobøse, T Mandrup-Poulsen, A E Karlsen, J Rasschaert, S Sandler, Nils Billestrup

27 Citations (Scopus)

Abstract

The pro-inflammatory cytokines IL-1 and IFNgamma are critical molecules in immune-mediated beta cell destruction leading to type 1 diabetes mellitus. Suppressor of cytokine signalling (SOCS)-3 inhibits the cytokine-mediated destruction of insulinoma-1 cells. Here we investigate the effect of SOCS3 in primary rodent beta cells and diabetic animal models.
Original languageEnglish
JournalDiabetologia
Volume51
Issue number10
Pages (from-to)1873-1882
Number of pages10
ISSN0012-186X
DOIs
Publication statusPublished - 2008

Keywords

  • Alloxan
  • Animals
  • Animals, Newborn
  • Apoptosis
  • Blotting, Western
  • Cytokines
  • Diabetes Mellitus, Experimental
  • Graft Survival
  • Humans
  • In Situ Nick-End Labeling
  • Islets of Langerhans
  • Islets of Langerhans Transplantation
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Mice, Transgenic
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Suppressor of Cytokine Signaling Proteins
  • Transplantation, Homologous

Fingerprint

Dive into the research topics of 'Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection'. Together they form a unique fingerprint.

Cite this